270395983	270395983	CD	B-NP	O
|	|	NN	I-NP	O
YVH	YVH	NN	I-NP	O
|	|	NN	I-NP	O
90514880	90514880	CD	I-NP	O
|	|	NN	I-NP	O
|	|	NN	I-NP	O
7048485	7048485	CD	B-NP	O
|	|	CC	I-NP	O
11/20/2005	11/20/2005	CD	I-NP	O
12	12	CD	I-NP	O
:	:	:	O	O
00	00	CD	B-NP	O
:	:	:	O	O
00	00	CD	B-NP	O
AM	AM	VBP	B-VP	O
|	|	JJ	B-NP	B-protein
CHEST	CHEST	NNP	I-NP	I-protein
PAIN	PAIN	NNP	I-NP	I-protein
|	|	NNP	I-NP	O
Unsigned	Unsigned	NNP	I-NP	O
|	|	NNP	I-NP	O
DIS	DIS	NNP	I-NP	O
|	|	NNP	I-NP	O
Admission	Admission	NNP	I-NP	O
Date	Date	NNP	I-NP	O
:	:	:	O	O
11/20/2005	11/20/2005	CD	B-NP	O
Report	Report	NNP	I-NP	O
Status	Status	NNP	I-NP	O
:	:	:	O	O
Unsigned	Unsigned	NNP	B-NP	O
Discharge	Discharge	NNP	I-NP	O
Date	Date	NNP	I-NP	O
:	:	:	O	O
10/8/2005	10/8/2005	CD	B-NP	O
ATTENDING	ATTENDING	NN	I-NP	O
:	:	:	O	O
LORENSON	LORENSON	NN	B-NP	O
,	,	,	O	O
REED	REED	NNP	B-NP	O
MD	MD	NNP	I-NP	O
SERVICE	SERVICE	NNP	I-NP	O
:	:	:	O	O
RBMC	RBMC	NN	B-NP	B-protein
.	.	.	O	O

ADMITTING	ADMITTING	VBG	B-VP	O
DIAGNOSIS	DIAGNOSIS	NN	B-NP	O
:	:	:	O	O
Rule	Rule	NNP	B-NP	O
out	out	IN	B-PP	O
MI	MI	NNP	B-NP	O
.	.	.	O	O

PRINCIPAL	PRINCIPAL	JJ	B-NP	O
DISCHARGE	DISCHARGE	NN	I-NP	O
DIAGNOSES	DIAGNOSES	NNS	I-NP	O
:	:	:	O	O
Angina	Angina	NNP	B-NP	O
,	,	,	O	O
tachycardia	tachycardia	NN	B-NP	O
,	,	,	O	O
and	and	CC	O	O
hypertension	hypertension	NN	B-NP	O
.	.	.	O	O

OTHER	OTHER	NN	B-NP	O
DIAGNOSES	DIAGNOSES	NNS	I-NP	O
:	:	:	O	O
Hypertension	Hypertension	NN	B-NP	O
,	,	,	O	O
chest	chest	NN	B-NP	O
pain	pain	NN	I-NP	O
,	,	,	O	O
GERD	GERD	NN	B-NP	O
,	,	,	O	O
coronary	coronary	JJ	B-NP	O
artery	artery	NN	I-NP	O
disease	disease	NN	I-NP	O
,	,	,	O	O
osteoarthritis	osteoarthritis	NN	B-NP	O
,	,	,	O	O
anxiety	anxiety	NN	B-NP	O
,	,	,	O	O
diverticulosis	diverticulosis	NN	B-NP	O
,	,	,	O	O
hypercholesterolemia	hypercholesterolemia	NN	B-NP	O
,	,	,	O	O
and	and	CC	O	O
chronic	chronic	JJ	B-NP	O
dizziness	dizziness	NN	I-NP	O
.	.	.	O	O

HISTORY	HISTORY	NN	B-NP	O
OF	OF	IN	B-PP	O
PRESENT	PRESENT	JJ	B-NP	O
ILLNESS	ILLNESS	NN	I-NP	O
:	:	:	O	O
The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
is	be	VBZ	B-VP	O
an	an	DT	B-NP	O
80-year-old	80-year-old	JJ	I-NP	O
woman	woman	NN	I-NP	O
with	with	IN	B-PP	O
history	history	NN	B-NP	O
of	of	IN	B-PP	O
coronary	coronary	JJ	B-NP	O
artery	artery	NN	I-NP	O
disease	disease	NN	I-NP	O
and	and	CC	O	O
difficult	difficult	JJ	B-ADJP	O
to	to	TO	B-VP	O
control	control	VB	I-VP	O
hypertension	hypertension	NN	B-NP	O
who	who	WP	B-NP	O
presented	present	VBD	B-VP	O
with	with	IN	B-PP	O
chest	chest	NN	B-NP	O
pain	pain	NN	I-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
setting	setting	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
elevated	elevated	JJ	I-NP	O
blood	blood	NN	I-NP	O
pressure	pressure	NN	I-NP	O
and	and	CC	I-NP	O
tachycardia	tachycardia	NN	I-NP	O
.	.	.	O	O

Two	Two	CD	B-NP	O
days	day	NNS	I-NP	O
prior	prior	RB	B-ADVP	O
to	to	TO	B-PP	O
admission	admission	NN	B-NP	O
,	,	,	O	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
had	have	VBD	B-VP	O
developed	develop	VBN	I-VP	O
the	the	DT	B-NP	O
abrupt	abrupt	JJ	I-NP	O
onset	onset	NN	I-NP	O
of	of	IN	B-PP	O
palpitation	palpitation	NN	B-NP	O
,	,	,	O	O
chest	chest	NN	B-NP	O
pain	pain	NN	I-NP	O
,	,	,	O	O
diaphoresis	diaphoresis	NN	B-NP	O
,	,	,	O	O
anxiety	anxiety	NN	B-NP	O
,	,	,	O	O
and	and	CC	O	O
shortness	shortness	NN	B-NP	O
of	of	IN	B-PP	O
breath	breath	NN	B-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
took	take	VBD	B-VP	O
her	her	PRP$	B-NP	O
blood	blood	NN	I-NP	O
pressure	pressure	NN	I-NP	O
and	and	CC	O	O
this	this	DT	B-NP	O
was	be	VBD	B-VP	O
found	find	VBN	I-VP	O
to	to	TO	I-VP	O
be	be	VB	I-VP	O
greater	great	JJR	B-ADJP	O
than	than	IN	B-PP	O
200	200	CD	B-NP	O
with	with	IN	B-PP	O
the	the	DT	B-NP	O
rapid	rapid	JJ	I-NP	O
pulse	pulse	NN	I-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
called	call	VBD	B-VP	O
her	her	PRP$	B-NP	O
PCP	PCP	NN	I-NP	O
and	and	CC	O	O
was	be	VBD	B-VP	O
instructed	instruct	VBN	I-VP	O
to	to	TO	I-VP	O
call	call	VB	I-VP	O
911	911	CD	B-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
was	be	VBD	B-VP	O
taken	take	VBN	I-VP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
Ha	Ha	NNP	I-NP	O
Hstibrook	Hstibrook	NNP	I-NP	O
Medical	Medical	NNP	I-NP	O
Center	Center	NNP	I-NP	O
ED	ED	NNP	I-NP	O
.	.	.	O	O

Of	Of	IN	B-PP	O
note	note	NN	B-NP	O
,	,	,	O	O
she	she	PRP	B-NP	O
had	have	VBD	B-VP	O
not	not	RB	I-VP	O
taken	take	VBN	I-VP	O
her	her	PRP$	B-NP	O
Toprol-XL	Toprol-XL	NN	I-NP	B-protein
for	for	IN	B-PP	O
the	the	DT	B-NP	O
prior	prior	JJ	I-NP	O
three	three	CD	I-NP	O
days	day	NNS	I-NP	O
.	.	.	O	O

In	In	IN	B-PP	O
the	the	DT	B-NP	O
emergency	emergency	NN	I-NP	O
department	department	NN	I-NP	O
,	,	,	O	O
the	the	DT	B-NP	O
systolic	systolic	JJ	I-NP	O
blood	blood	NN	I-NP	O
pressure	pressure	NN	I-NP	O
was	be	VBD	B-VP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
180s	180	NNS	I-NP	B-DNA
.	.	.	O	O

This	This	DT	B-NP	O
was	be	VBD	B-VP	O
controlled	control	VBN	I-VP	O
with	with	IN	B-PP	O
her	her	PRP$	B-NP	O
home	home	NN	I-NP	O
medications	medication	NNS	I-NP	O
and	and	CC	O	O
IV	IV	CD	B-NP	O
Lopressor	Lopressor	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
ruled	rule	VBN	I-VP	O
out	out	RP	B-PRT	O
for	for	IN	B-PP	O
an	an	DT	B-NP	O
MI	MI	NN	I-NP	O
in	in	IN	B-PP	O
ED/OBS	ED/OBS	NNP	B-NP	B-protein
.	.	.	O	O

She	She	PRP	B-NP	O
went	go	VBD	B-VP	O
for	for	IN	B-PP	O
a	a	DT	B-NP	O
MIBI	MIBI	NNP	I-NP	O
on	on	IN	B-PP	O
the	the	DT	B-NP	O
morning	morning	NN	I-NP	O
of	of	IN	B-PP	O
admission	admission	NN	B-NP	O
,	,	,	O	O
but	but	CC	O	O
this	this	DT	B-NP	O
was	be	VBD	B-VP	O
canceled	cancel	VBN	I-VP	O
because	because	IN	B-SBAR	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
dizzy	dizzy	JJ	B-ADJP	O
.	.	.	O	O

Of	Of	IN	B-PP	O
note	note	NN	B-NP	O
,	,	,	O	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
has	have	VBZ	B-VP	O
had	have	VBN	I-VP	O
an	an	DT	B-NP	O
identical	identical	JJ	I-NP	O
admission	admission	NN	I-NP	O
several	several	JJ	B-NP	O
months	month	NNS	I-NP	O
earlier	earlier	RB	B-ADVP	O
for	for	IN	B-PP	O
a	a	DT	B-NP	O
labile	labile	JJ	I-NP	O
blood	blood	NN	I-NP	O
pressure	pressure	NN	I-NP	O
.	.	.	O	O

During	During	IN	B-PP	O
that	that	DT	B-NP	O
admission	admission	NN	I-NP	O
,	,	,	O	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
's	's	POS	B-NP	O
hydralazine	hydralazine	NN	I-NP	O
and	and	CC	I-NP	O
beta-blocker	beta-blocker	NN	I-NP	O
was	be	VBD	B-VP	O
titrated	titrate	VBN	I-VP	O
up	up	RP	B-PRT	O
with	with	IN	B-PP	O
improved	improve	VBN	B-NP	O
blood	blood	NN	I-NP	O
pressure	pressure	NN	I-NP	O
control	control	NN	I-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
was	be	VBD	B-VP	O
ruled	rule	VBN	I-VP	O
out	out	RP	B-PRT	O
for	for	IN	B-PP	O
pheochromocytoma	pheochromocytoma	NN	B-NP	O
and	and	CC	O	O
renal	renal	JJ	B-NP	O
artery	artery	NN	I-NP	O
stenosis	stenosis	NN	I-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
did	do	VBD	B-VP	O
have	have	VB	I-VP	O
elevated	elevate	VBN	I-VP	O
plasma	plasma	NN	B-NP	O
metanephrines	metanephrine	NNS	I-NP	O
during	during	IN	B-PP	O
that	that	DT	B-NP	O
admission	admission	NN	I-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
was	be	VBD	B-VP	O
discharged	discharge	VBN	I-VP	O
at	at	IN	B-PP	O
that	that	DT	B-NP	O
point	point	NN	I-NP	O
on	on	IN	B-PP	O
an	an	DT	B-NP	O
improved	improve	VBN	I-NP	O
antihypertensive	antihypertensive	JJ	I-NP	O
regimen	regimen	NN	I-NP	O
as	as	IN	B-SBAR	O
described	describe	VBN	B-VP	O
above	above	RB	B-ADVP	O
.	.	.	O	O

She	She	PRP	B-NP	O
also	also	RB	B-ADVP	O
reports	report	VBZ	B-VP	O
having	have	VBG	I-VP	O
had	have	VBD	I-VP	O
a	a	DT	B-NP	O
similar	similar	JJ	I-NP	O
episode	episode	NN	I-NP	O
two	two	CD	B-NP	O
weeks	week	NNS	I-NP	O
ago	ago	RB	B-ADVP	O
.	.	.	O	O

PAST	PAST	NNP	B-NP	O
MEDICAL	MEDICAL	NNP	I-NP	O
HISTORY	HISTORY	NNP	I-NP	O
:	:	:	O	O
Hypertension	Hypertension	NN	B-NP	O
,	,	,	O	O
angina	angina	NN	B-NP	O
,	,	,	O	O
osteoarthritis	osteoarthritis	NN	B-NP	O
,	,	,	O	O
GERD	GERD	NN	B-NP	O
,	,	,	O	O
diverticulosis	diverticulosis	NN	B-NP	O
,	,	,	O	O
hyperlipidemia	hyperlipidemia	NN	B-NP	O
,	,	,	O	O
coronary	coronary	JJ	B-NP	O
artery	artery	NN	I-NP	O
disease	disease	NN	I-NP	O
status	status	NN	I-NP	O
post	post	NN	I-NP	O
CABG	CABG	NN	I-NP	O
x4	x4	NN	I-NP	O
and	and	CC	O	O
multiple	multiple	JJ	B-NP	O
stents	stent	NNS	I-NP	O
,	,	,	O	O
chronic	chronic	JJ	B-NP	O
dizziness	dizziness	NN	I-NP	O
,	,	,	O	O
stable	stable	JJ	B-NP	O
cath	cath	NN	I-NP	O
8/4	8/4	CD	I-NP	O
.	.	.	O	O

HOME	HOME	NN	B-NP	O
MEDICATIONS	MEDICATIONS	NNS	I-NP	O
:	:	:	O	O
1	1	LS	B-LST	O
.	.	.	O	O

Aspirin	Aspirin	NN	B-NP	O
81	81	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	RB	B-ADVP	O
daily	daily	RB	I-ADVP	O
.	.	.	O	O

2	2	LS	B-LST	O
.	.	.	O	O

Lasix	Lasix	NNP	B-NP	O
40	40	CD	I-NP	O
mg	mg	NN	I-NP	O
daily	daily	RB	B-ADVP	O
.	.	.	O	O

3	3	LS	B-LST	O
.	.	.	O	O

Hydralazine	Hydralazine	NN	B-NP	O
10	10	CD	I-NP	O
mg	mg	NN	I-NP	O
q.	q.	NN	I-NP	O
8h	8h	NN	I-NP	O
.	.	.	O	O

4	4	LS	B-LST	O
.	.	.	O	O

Ibuprofen	Ibuprofen	NN	B-NP	O
400	400	CD	I-NP	O
mg	mg	NN	I-NP	O
q.	q.	NN	I-NP	O
8h	8h	NN	I-NP	O
.	.	.	O	O

p.r.n.	p.r.n.	RB	B-NP	O
5	5	CD	I-NP	O
.	.	.	O	O

Propoxyphene	Propoxyphene	NN	B-NP	O
1-2	1-2	CD	I-NP	O
tablets	tablet	NNS	I-NP	O
q.	q.	NN	I-NP	O
8h	8h	NN	I-NP	O
.	.	.	O	O

p.r.n.	p.r.n.	RB	B-NP	O
6	6	CD	I-NP	O
.	.	.	O	O

Ativan	Ativan	IN	B-PP	O
0.5	0.5	CD	B-NP	O
mg	mg	NN	I-NP	O
daily	daily	JJ	I-NP	O
p.r.n.	p.r.n.	NN	I-NP	O
7	7	CD	I-NP	O
.	.	.	O	O

Lactulose	Lactulose	NN	B-NP	B-protein
p.r.n.	p.r.n.	NN	I-NP	I-protein
8	8	CD	I-NP	I-protein
.	.	.	O	O

Tylenol	Tylenol	NN	B-NP	B-protein
p.r.n.	p.r.n.	NN	I-NP	I-protein
9	9	CD	I-NP	I-protein
.	.	.	O	O

Sublingual	Sublingual	JJ	B-NP	O
nitroglycerin	nitroglycerin	NN	I-NP	O
p.r.n.	p.r.n.	NN	I-NP	O
10	10	CD	I-NP	O
.	.	.	O	O

Nexium	Nexium	NN	B-NP	O
20	20	CD	I-NP	O
mg	mg	NN	I-NP	O
daily	daily	RB	B-ADVP	O
.	.	.	O	O

11	11	CD	B-NP	O
.	.	.	O	O

Meclizine	Meclizine	NN	B-NP	O
125	125	CD	I-NP	O
mg	mg	NN	I-NP	O
t.i.d.	t.i.d.	NN	I-NP	O
p.r.n.	p.r.n.	NN	I-NP	O
12	12	CD	I-NP	O
.	.	.	O	O

Avapro	Avapro	IN	B-PP	O
300	300	CD	B-NP	O
mg	mg	NN	I-NP	O
daily	daily	RB	B-ADVP	O
.	.	.	O	O

13	13	CD	B-NP	O
.	.	.	O	O

Celexa	Celexa	NN	B-NP	O
10	10	CD	I-NP	O
mg	mg	NN	I-NP	O
daily	daily	RB	B-ADVP	O
.	.	.	O	O

14	14	CD	B-NP	O
.	.	.	O	O

Lipitor	Lipitor	NN	B-NP	O
20	20	CD	I-NP	O
mg	mg	NN	I-NP	O
daily	daily	RB	B-ADVP	O
.	.	.	O	O

15	15	CD	B-NP	O
.	.	.	O	O

Imdur	Imdur	IN	B-PP	O
120	120	CD	B-NP	O
mg	mg	NN	I-NP	O
daily	daily	RB	B-ADVP	O
.	.	.	O	O

16	16	CD	B-NP	O
.	.	.	O	O

Toprol	Toprol	NN	B-NP	B-protein
100	100	CD	I-NP	I-protein
mg	mg	NN	I-NP	I-protein
daily	daily	JJ	I-NP	I-protein
-LRB-	-LRB-	NN	I-NP	I-protein
held	hold	VBN	B-VP	O
last	last	JJ	B-NP	O
several	several	JJ	I-NP	O
days	day	NNS	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
.	.	.	O	O

ALLERGIES	ALLERGIES	NNS	B-NP	O
:	:	:	O	O
ACE	ACE	NN	B-NP	O
inhibitor	inhibitor	NN	I-NP	O
,	,	,	O	O
amlodipine	amlodipine	NN	B-NP	O
,	,	,	O	O
and	and	CC	O	O
niacin	niacin	NN	B-NP	O
.	.	.	O	O

SOCIAL	SOCIAL	JJ	B-NP	O
HISTORY	HISTORY	NN	I-NP	O
:	:	:	O	O
No	No	DT	B-NP	O
smoking	smoking	NN	I-NP	O
,	,	,	O	O
no	no	DT	B-NP	O
ethanol	ethanol	NN	I-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
lives	live	VBZ	B-VP	O
in	in	IN	B-PP	O
West	West	NNP	B-NP	O
O	O	NNP	I-NP	O
Uxkan	Uxkan	NNP	I-NP	O
by	by	IN	B-PP	O
herself	herself	PRP	B-NP	O
,	,	,	O	O
has	have	VBZ	B-VP	O
a	a	DT	B-NP	O
helper	helper	NN	I-NP	B-protein
-LRB-	-LRB-	NN	I-NP	I-protein
visiting	visit	VBG	B-VP	I-protein
aid	aid	NN	B-NP	I-protein
-RRB-	-RRB-	NN	I-NP	I-protein
.	.	.	O	O

No	No	DT	B-NP	O
family	family	NN	I-NP	O
nearby	nearby	RB	B-ADVP	O
.	.	.	O	O

Her	Her	PRP$	B-NP	O
family	family	NN	I-NP	O
lives	life	NNS	I-NP	O
in	in	IN	B-PP	O
Pit	Pit	NNP	B-NP	O
Forda	Forda	NNP	I-NP	O
Sta	Sta	NNP	I-NP	O
FAMILY	FAMILY	NNP	I-NP	O
HISTORY	HISTORY	NNP	I-NP	O
:	:	:	O	O
Her	Her	PRP$	B-NP	O
brother	brother	NN	I-NP	O
died	die	VBD	B-VP	O
at	at	IN	B-PP	O
61	61	CD	B-NP	O
years	year	NNS	I-NP	O
old	old	JJ	B-ADJP	O
of	of	IN	B-PP	O
CVA	CVA	NN	B-NP	B-protein
.	.	.	O	O

Her	Her	PRP$	B-NP	O
mother	mother	NN	I-NP	O
died	die	VBD	B-VP	O
at	at	IN	B-PP	O
75	75	CD	B-NP	O
years	year	NNS	I-NP	O
old	old	JJ	B-ADJP	O
with	with	IN	B-PP	O
CVA	CVA	NN	B-NP	B-protein
.	.	.	O	O

Her	Her	PRP$	B-NP	O
sister	sister	NN	I-NP	O
had	have	VBD	B-VP	O
an	an	DT	B-NP	O
MI	MI	NN	I-NP	O
at	at	IN	B-PP	O
age	age	NN	B-NP	O
80	80	CD	I-NP	O
.	.	.	O	O

PHYSICAL	PHYSICAL	NN	B-NP	O
EXAMINATION	EXAMINATION	NN	I-NP	O
ON	ON	NN	I-NP	O
ADMISSION	ADMISSION	NN	I-NP	O
:	:	:	O	O
Vital	Vital	JJ	B-NP	O
signs	sign	NNS	I-NP	O
:	:	:	O	O
Heart	Heart	NN	B-NP	O
rate	rate	NN	I-NP	O
98	98	CD	B-NP	O
,	,	,	O	O
blood	blood	NN	B-NP	O
pressure	pressure	NN	I-NP	O
172/70	172/70	CD	I-NP	O
with	with	IN	B-PP	O
a	a	DT	B-NP	O
range	range	NN	I-NP	O
of	of	IN	B-PP	O
103-172/40	103-172/40	CD	B-NP	O
-70	-70	CD	I-NP	O
.	.	.	O	O

O2	O2	NN	B-NP	O
saturation	saturation	NN	I-NP	O
was	be	VBD	B-VP	O
97	97	CD	B-NP	O
%	%	NN	I-NP	O
on	on	IN	B-PP	O
room	room	NN	B-NP	O
air	air	NN	I-NP	O
.	.	.	O	O

Her	Her	PRP$	B-NP	O
exam	exam	NN	I-NP	O
was	be	VBD	B-VP	O
significant	significant	JJ	B-ADJP	O
for	for	IN	B-PP	O
tachycardia	tachycardia	NN	B-NP	O
with	with	IN	B-PP	O
a	a	DT	B-NP	O
regular	regular	JJ	I-NP	O
rate	rate	NN	I-NP	O
,	,	,	O	O
normal	normal	JJ	B-NP	O
S1	S1	NN	I-NP	B-protein
and	and	CC	O	O
S2	S2	NN	B-NP	B-protein
,	,	,	O	O
and	and	CC	O	O
soft	soft	JJ	B-NP	O
systolic	systolic	JJ	I-NP	O
ejection	ejection	NN	I-NP	O
murmur	murmur	NN	I-NP	O
at	at	IN	B-PP	O
the	the	DT	B-NP	O
right	right	JJ	I-NP	O
upper	upper	JJ	I-NP	O
sternal	sternal	JJ	I-NP	O
border	border	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
remainder	remainder	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
exam	exam	NN	I-NP	O
was	be	VBD	B-VP	O
unremarkable	unremarkable	JJ	B-ADJP	O
.	.	.	O	O

LABS	LABS	NN	B-NP	O
ON	ON	NN	I-NP	O
ADMISSION	ADMISSION	NN	I-NP	O
:	:	:	O	O
CBC	CBC	NN	B-NP	B-protein
was	be	VBD	B-VP	O
within	within	IN	B-PP	O
normal	normal	JJ	B-NP	O
limits	limit	NNS	I-NP	O
.	.	.	O	O

Chem-7	Chem-7	NN	B-NP	B-protein
was	be	VBD	B-VP	O
significant	significant	JJ	B-ADJP	O
for	for	IN	B-PP	O
BUN	BUN	NN	B-NP	O
of	of	IN	B-PP	O
22	22	CD	B-NP	O
and	and	CC	O	O
creatinine	creatinine	NN	B-NP	O
of	of	IN	B-PP	O
103	103	CD	B-NP	O
.	.	.	O	O

Calcium	Calcium	NN	B-NP	O
was	be	VBD	B-VP	O
10.5	10.5	CD	B-NP	O
,	,	,	O	O
phosphorus	phosphorus	NN	B-NP	O
was	be	VBD	B-VP	O
2.5	2.5	CD	B-NP	O
,	,	,	O	O
and	and	CC	O	O
albumin	albumin	NN	B-NP	B-protein
was	be	VBD	B-VP	O
4.3	4.3	CD	B-NP	O
.	.	.	O	O

LFTs	LFT	NNS	B-NP	B-protein
were	be	VBD	B-VP	O
normal	normal	JJ	B-ADJP	O
.	.	.	O	O

Her	Her	PRP$	B-NP	O
D-dimer	D-dimer	NN	I-NP	B-protein
was	be	VBD	B-VP	O
1305	1305	CD	B-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
had	have	VBD	B-VP	O
two	two	CD	B-NP	O
sets	set	NNS	I-NP	O
of	of	IN	B-PP	O
negative	negative	JJ	B-NP	B-protein
cardiac	cardiac	JJ	I-NP	I-protein
enzymes	enzyme	NNS	I-NP	I-protein
.	.	.	O	O

Coags	Coag	NNS	B-NP	O
were	be	VBD	B-VP	O
normal	normal	JJ	B-ADJP	O
.	.	.	O	O

EKG	EKG	NN	B-NP	O
:	:	:	O	O
Normal	Normal	JJ	B-NP	O
sinus	sinus	NN	I-NP	O
rhythm	rhythm	NN	I-NP	O
at	at	IN	B-PP	O
the	the	DT	B-NP	O
rate	rate	NN	I-NP	O
of	of	IN	B-PP	O
75	75	CD	B-NP	O
beats	beat	NNS	I-NP	O
per	per	IN	B-PP	O
minute	minute	NN	B-NP	O
,	,	,	O	O
left	leave	VBD	B-VP	O
axis	axis	NN	B-NP	O
deviation	deviation	NN	I-NP	O
,	,	,	O	O
LVH	LVH	NN	B-NP	B-protein
,	,	,	O	O
left	leave	VBD	B-VP	O
atrial	atrial	JJ	B-NP	O
enlargement	enlargement	NN	I-NP	O
.	.	.	O	O

T-wave	T-wave	NN	B-NP	O
flatting	flat	VBG	B-VP	O
in	in	IN	B-PP	O
lead	lead	NN	B-NP	O
III	III	CD	I-NP	O
only	only	RB	B-ADVP	O
.	.	.	O	O

STUDIES	STUDIES	NNS	B-NP	O
:	:	:	O	O
1	1	LS	B-LST	O
.	.	.	O	O

Chest	Chest	NNP	B-NP	O
x-ray	x-ray	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
9/29/05	9/29/05	CD	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
:	:	:	O	O
No	No	DT	B-NP	O
acute	acute	JJ	I-NP	O
cardiopulmonary	cardiopulmonary	JJ	I-NP	O
process	process	NN	I-NP	O
.	.	.	O	O

2	2	LS	B-LST	O
.	.	.	O	O

PE	PE	NN	B-NP	B-protein
CT	CT	NN	I-NP	I-protein
-LRB-	-LRB-	HYPH	O	O
11/9/05	11/9/05	CD	B-NP	O
-RRB-	-RRB-	NN	I-NP	O
:	:	:	O	O
No	No	DT	B-NP	O
PE	PE	NN	I-NP	O
.	.	.	O	O

3	3	LS	B-LST	O
.	.	.	O	O

Head	Head	NN	B-NP	O
CT	CT	NN	I-NP	O
-LRB-	-LRB-	HYPH	O	O
11/9/05	11/9/05	CD	B-NP	O
-RRB-	-RRB-	NN	I-NP	O
:	:	:	O	O
Left-sided	Left-sided	JJ	B-NP	O
meningiomas	meningioma	NNS	I-NP	O
,	,	,	O	O
unchanged	unchanged	JJ	B-ADJP	O
from	from	IN	B-PP	O
2004	2004	CD	B-NP	O
.	.	.	O	O

4	4	LS	B-LST	O
.	.	.	O	O

MIBI	MIBI	NNP	B-NP	O
-LRB-	-LRB-	NNP	I-NP	O
10/27/05	10/27/05	CD	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
:	:	:	O	O
Area	Area	NN	B-NP	O
of	of	IN	B-PP	O
reversible	reversible	JJ	B-NP	O
ischemia	ischemia	NN	I-NP	O
,	,	,	O	O
unchanged	unchanged	JJ	B-ADJP	O
from	from	IN	B-PP	O
2002	2002	CD	B-NP	O
.	.	.	O	O

CONSULTS	CONSULTS	NNS	B-NP	O
:	:	:	O	O
Cardiology	Cardiology	NNP	B-NP	O
-LRB-	-LRB-	NNP	I-NP	O
FMCO	FMCO	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
:	:	:	O	O
Luke	Luke	NNP	B-NP	O
Ollie	Ollie	NNP	I-NP	O
Buckley	Buckley	NNP	I-NP	O
.	.	.	O	O

HOSPITAL	HOSPITAL	NNP	B-NP	O
COURSE	COURSE	NNP	I-NP	O
BY	BY	NNP	I-NP	O
PROBLEMS	PROBLEMS	NNP	I-NP	O
:	:	:	O	O
1	1	CD	B-NP	O
.	.	.	O	O

Paroxysmal	Paroxysmal	JJ	B-NP	O
hypertension/tachycardia	hypertension/tachycardia	NN	I-NP	O
:	:	:	O	O
This	This	DT	B-NP	O
was	be	VBD	B-VP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
setting	setting	NN	I-NP	O
of	of	IN	B-PP	O
not	not	RB	B-VP	O
taking	take	VBG	I-VP	O
her	her	PRP$	B-NP	O
Toprol	Toprol	NN	I-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
does	do	VBZ	B-VP	O
have	have	VB	I-VP	O
a	a	DT	B-NP	O
history	history	NN	I-NP	O
of	of	IN	B-PP	O
labile	labile	JJ	B-NP	O
blood	blood	NN	I-NP	O
pressure	pressure	NN	I-NP	O
and	and	CC	O	O
difficult	difficult	JJ	B-ADJP	O
to	to	TO	B-PP	O
control	control	NN	B-NP	O
hypertension	hypertension	NN	I-NP	O
.	.	.	O	O

This	This	DT	B-NP	O
symptom	symptom	NN	I-NP	O
was	be	VBD	B-VP	O
thought	think	VBN	I-VP	O
to	to	TO	I-VP	O
look	look	VB	I-VP	O
very	very	RB	B-ADVP	O
much	much	RB	I-ADVP	O
like	like	IN	B-PP	O
pheochromocytoma	pheochromocytoma	NN	B-NP	O
,	,	,	O	O
but	but	CC	O	O
this	this	DT	B-NP	O
was	be	VBD	B-VP	O
ruled	rule	VBN	I-VP	O
out	out	RP	B-PRT	O
last	last	JJ	B-NP	O
admission	admission	NN	I-NP	O
.	.	.	O	O

Renal	Renal	JJ	B-NP	O
artery	artery	NN	I-NP	O
stenosis	stenosis	NN	I-NP	O
was	be	VBD	B-VP	O
also	also	RB	I-VP	O
ruled	rule	VBN	I-VP	O
out	out	RP	B-PRT	O
last	last	JJ	B-NP	O
admission	admission	NN	I-NP	O
.	.	.	O	O

Given	Give	VBN	B-PP	O
the	the	DT	B-NP	O
description	description	NN	I-NP	O
and	and	CC	O	O
the	the	DT	B-NP	O
fact	fact	NN	I-NP	O
that	that	IN	B-SBAR	O
she	she	PRP	B-NP	O
had	have	VBD	B-VP	O
elevated	elevate	VBN	I-VP	O
plasma	plasma	NN	B-NP	O
metanephrines	metanephrine	NNS	I-NP	O
on	on	IN	B-PP	O
the	the	DT	B-NP	O
previous	previous	JJ	I-NP	O
admission	admission	NN	I-NP	O
,	,	,	O	O
one	one	CD	B-NP	O
possible	possible	JJ	I-NP	O
diagnosis	diagnosis	NN	I-NP	O
that	that	WDT	B-NP	O
was	be	VBD	B-VP	O
considered	consider	VBN	I-VP	O
with	with	IN	B-PP	O
pseudo	pseudo	NN	B-NP	O
pheochromocytoma	pheochromocytoma	NN	I-NP	O
.	.	.	O	O

Studies	Study	NNS	B-NP	O
for	for	IN	B-PP	O
pheochromocytoma	pheochromocytoma	NN	B-NP	O
,	,	,	O	O
pseudo	pseudo	NN	B-NP	O
pheochromocytoma	pheochromocytoma	NN	I-NP	O
,	,	,	O	O
carcinoid	carcinoid	NN	B-NP	O
,	,	,	O	O
and	and	CC	O	O
hypothyroidism	hypothyroidism	NN	B-NP	O
-LRB-	-LRB-	NN	I-NP	O
including	include	VBG	B-PP	O
24-hour	24-hour	JJ	B-NP	O
urine	urine	NN	I-NP	O
metanephrines	metanephrine	NNS	I-NP	O
were	be	VBD	B-VP	O
sent	send	VBN	I-VP	O
-RRB-	-RRB-	TO	B-PP	O
these	these	DT	B-NP	O
all	all	DT	I-NP	O
returned	return	VBD	B-VP	O
as	as	IN	B-PP	O
negative	negative	JJ	B-ADJP	O
.	.	.	O	O

Her	Her	PRP$	B-NP	O
TSH	TSH	NN	I-NP	O
was	be	VBD	B-VP	O
normal	normal	JJ	B-ADJP	O
.	.	.	O	O

She	She	PRP	B-NP	O
was	be	VBD	B-VP	O
initially	initially	RB	I-VP	O
put	put	VBN	I-VP	O
on	on	IN	B-PP	O
q.i.d.	q.i.d.	NN	B-NP	O
Lopressor	Lopressor	NN	I-NP	O
and	and	CC	I-NP	O
hydralazine	hydralazine	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
hydralazine	hydralazine	NN	I-NP	O
was	be	VBD	B-VP	O
then	then	RB	I-VP	O
discontinued	discontinue	VBN	I-VP	O
due	due	JJ	B-ADJP	O
to	to	TO	B-PP	O
hypotension	hypotension	NN	B-NP	O
.	.	.	O	O

Her	Her	PRP$	B-NP	O
Lopressor	Lopressor	NN	I-NP	O
was	be	VBD	B-VP	O
changed	change	VBN	I-VP	O
to	to	TO	B-PP	O
Toprol-XL	Toprol-XL	NNP	B-NP	O
,	,	,	O	O
this	this	DT	B-NP	O
was	be	VBD	B-VP	O
also	also	RB	I-VP	O
discontinued	discontinue	VBN	I-VP	O
for	for	IN	B-PP	O
hypotension	hypotension	NN	B-NP	O
.	.	.	O	O

Her	Her	PRP$	B-NP	O
ultimate	ultimate	JJ	I-NP	O
regimen	regimen	NN	I-NP	O
was	be	VBD	B-VP	O
titrated	titrate	VBN	I-VP	O
based	base	VBN	B-PP	O
on	on	IN	B-PP	O
her	her	PRP$	B-NP	O
blood	blood	NN	I-NP	O
pressures	pressure	NNS	I-NP	O
and	and	CC	O	O
eventually	eventually	RB	B-ADVP	O
she	she	PRP	B-NP	O
was	be	VBD	B-VP	O
put	put	VBN	I-VP	O
on	on	IN	B-PP	O
Avapro	Avapro	NNP	B-NP	O
75	75	CD	I-NP	O
mg	mg	NN	I-NP	O
daily	daily	JJ	I-NP	O
,	,	,	O	O
atenolol	atenolol	NN	B-NP	O
25	25	CD	I-NP	O
mg	mg	NN	I-NP	O
daily	daily	JJ	B-ADJP	O
,	,	,	O	O
and	and	CC	O	O
her	her	PRP$	B-NP	O
home	home	NN	I-NP	O
dose	dose	NN	I-NP	O
of	of	IN	B-PP	O
Imdur	Imdur	NNP	B-NP	O
120	120	CD	I-NP	O
mg	mg	NN	I-NP	O
daily	daily	RB	B-ADVP	O
.	.	.	O	O

Her	Her	PRP$	B-NP	O
target	target	NN	I-NP	O
blood	blood	NN	I-NP	O
pressures	pressure	NNS	I-NP	O
were	be	VBD	B-VP	O
140s	140s	CD	B-NP	O
to	to	TO	B-PP	O
150s	150s	CD	B-NP	O
and	and	CC	O	O
with	with	IN	B-PP	O
this	this	DT	B-NP	O
regimen	regimen	NN	I-NP	O
,	,	,	O	O
she	she	PRP	B-NP	O
was	be	VBD	B-VP	O
well	well	RB	B-ADJP	O
controlled	controlled	JJ	I-ADJP	O
and	and	CC	I-ADJP	O
asymptomatic	asymptomatic	JJ	I-ADJP	O
upon	upon	IN	B-PP	O
discharge	discharge	NN	B-NP	O
.	.	.	O	O

2	2	LS	B-LST	O
.	.	.	O	O

Ischemia	Ischemia	NNP	B-NP	O
:	:	:	O	O
She	She	PRP	B-NP	O
was	be	VBD	B-VP	O
initially	initially	RB	I-VP	O
ruled	rule	VBN	I-VP	O
out	out	RP	B-PRT	O
for	for	IN	B-PP	O
MI	MI	NN	B-NP	O
.	.	.	O	O

Her	Her	PRP$	B-NP	O
MIBI	MIBI	NN	I-NP	B-protein
showed	show	VBD	B-VP	O
reversible	reversible	JJ	B-NP	O
ischemia	ischemia	NN	I-NP	O
unchanged	unchanged	JJ	B-ADJP	O
from	from	IN	B-PP	O
2002	2002	CD	B-NP	O
despite	despite	IN	B-PP	O
two	two	CD	B-NP	O
catheterizations	catheterization	NNS	I-NP	O
in	in	IN	B-PP	O
intervening	intervene	VBG	B-VP	O
time	time	NN	B-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
was	be	VBD	B-VP	O
seen	see	VBN	I-VP	O
by	by	IN	B-PP	O
LMH	LMH	NNP	B-NP	O
Cardiology	Cardiology	NNP	I-NP	O
,	,	,	O	O
and	and	CC	O	O
this	this	DT	B-NP	O
defect	defect	NN	I-NP	O
was	be	VBD	B-VP	O
felt	feel	VBN	I-VP	O
to	to	TO	I-VP	O
be	be	VB	I-VP	O
nonintervenable	nonintervenable	JJ	B-ADJP	O
.	.	.	O	O

She	She	PRP	B-NP	O
was	be	VBD	B-VP	O
discharged	discharge	VBN	I-VP	O
home	home	NN	B-ADVP	O
in	in	IN	B-PP	O
stable	stable	JJ	B-NP	O
condition	condition	NN	I-NP	O
and	and	CC	I-NP	O
chest	chest	NN	I-NP	O
pain	pain	NN	I-NP	O
free	free	JJ	B-ADJP	O
.	.	.	O	O

3	3	LS	B-LST	O
.	.	.	O	O

Dizziness/nausea	Dizziness/nausea	NNP	B-NP	O
:	:	:	O	O
She	She	PRP	B-NP	O
had	have	VBD	B-VP	O
episodes	episode	NNS	B-NP	O
of	of	IN	B-PP	O
this	this	DT	B-NP	O
during	during	IN	B-PP	O
her	her	PRP$	B-NP	O
hospitalization	hospitalization	NN	I-NP	O
.	.	.	O	O

It	It	PRP	B-NP	O
was	be	VBD	B-VP	O
of	of	IN	B-PP	O
unclear	unclear	JJ	B-NP	O
etiology	etiology	NN	I-NP	O
and	and	CC	O	O
she	she	PRP	B-NP	O
has	have	VBZ	B-VP	O
had	have	VBN	I-VP	O
a	a	DT	B-NP	O
previous	previous	JJ	I-NP	O
significant	significant	JJ	I-NP	O
prior	prior	JJ	I-NP	O
workup	workup	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
see	see	VBP	B-VP	O
previous	previous	JJ	B-NP	O
discharge	discharge	NN	I-NP	O
summary	summary	NN	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
received	receive	VBD	B-VP	O
p.r.n.	p.r.n.	NN	B-NP	O
meclizine	meclizine	NN	I-NP	O
and	and	CC	I-NP	O
Compazine	Compazine	NN	I-NP	O
and	and	CC	O	O
was	be	VBD	B-VP	O
discharged	discharge	VBN	I-VP	O
home	home	NN	B-ADVP	O
without	without	IN	B-PP	O
any	any	DT	B-NP	O
dizziness	dizziness	NN	I-NP	O
or	or	CC	I-NP	O
nausea	nausea	NN	I-NP	O
.	.	.	O	O

4	4	LS	B-LST	O
.	.	.	O	O

Calcium	Calcium	NN	B-NP	O
:	:	:	O	O
She	She	PRP	B-NP	O
had	have	VBD	B-VP	O
borderline	borderline	JJ	B-NP	O
high	high	JJ	I-NP	O
calcium	calcium	NN	I-NP	O
and	and	CC	O	O
a	a	DT	B-NP	O
PTH	PTH	NN	I-NP	B-protein
was	be	VBD	B-VP	O
sent	send	VBN	I-VP	O
and	and	CC	O	O
returned	return	VBN	B-VP	O
mildly	mildly	RB	B-VP	O
elevated	elevate	VBN	I-VP	O
.	.	.	O	O

This	This	DT	B-NP	O
will	will	MD	B-VP	O
need	need	VB	I-VP	O
to	to	TO	I-VP	O
be	be	VB	I-VP	O
followed	follow	VBN	I-VP	O
up	up	RP	B-PRT	O
as	as	IN	B-PP	O
an	an	DT	B-NP	O
outpatient	outpatient	NN	I-NP	O
.	.	.	O	O

DISCHARGE	DISCHARGE	NN	B-NP	O
CONDITION	CONDITION	NN	I-NP	O
:	:	:	O	O
Stable	Stable	JJ	B-ADJP	O
.	.	.	O	O

TO	TO	TO	B-PP	O
DO	DO	NNP	B-NP	O
PLAN	PLAN	NNP	I-NP	O
:	:	:	O	O
Further	Further	JJ	B-NP	O
workup	workup	NN	I-NP	O
for	for	IN	B-PP	O
question	question	NN	B-NP	O
of	of	IN	B-PP	O
elevated	elevated	JJ	B-NP	O
PTH	PTH	NN	I-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
setting	setting	NN	I-NP	O
of	of	IN	B-PP	O
high	high	JJ	B-NP	O
calcium	calcium	NN	I-NP	O
suggestive	suggestive	JJ	B-ADJP	O
of	of	IN	B-PP	O
hyperparathyroidism	hyperparathyroidism	NN	B-NP	O
.	.	.	O	O

DISCHARGE	DISCHARGE	NN	B-NP	O
MEDICATIONS	MEDICATIONS	NNS	I-NP	O
:	:	:	O	O
1	1	LS	B-LST	O
.	.	.	O	O

Aspirin	Aspirin	NN	B-NP	O
81	81	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	RB	B-ADVP	O
daily	daily	RB	I-ADVP	O
.	.	.	O	O

2	2	LS	B-LST	O
.	.	.	O	O

Atenolol	Atenolol	NN	B-NP	O
25	25	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	RB	B-ADVP	O
daily	daily	RB	I-ADVP	O
.	.	.	O	O

3	3	LS	B-LST	O
.	.	.	O	O

Colace	Colace	NNP	B-NP	O
100	100	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	NN	I-NP	O
b.i.d.	b.i.d.	NN	I-NP	O
4	4	CD	I-NP	O
.	.	.	O	O

Lasix	Lasix	NNP	B-NP	O
40	40	CD	I-NP	O
mg	mg	NN	I-NP	O
daily	daily	RB	B-ADVP	O
.	.	.	O	O

5	5	LS	B-LST	O
.	.	.	O	O

Ibuprofen	Ibuprofen	NN	B-NP	O
400	400	CD	I-NP	O
mg	mg	NN	I-NP	O
q.	q.	NN	I-NP	O
8h	8h	NN	I-NP	O
.	.	.	O	O

p.r.n.	p.r.n.	LS	B-NP	O
pain	pain	NN	I-NP	O
.	.	.	O	O

6	6	CD	B-NP	O
.	.	.	O	O

Lactulose	Lactulose	RB	B-NP	O
30	30	CD	I-NP	O
mL	mL	NN	I-NP	O
p.o.	p.o.	FW	B-NP	O
q.i.d.	q.i.d.	FW	I-NP	O
p.r.n.	p.r.n.	NN	I-NP	O
constipation	constipation	NN	I-NP	O
.	.	.	O	O

7	7	CD	B-NP	O
.	.	.	O	O

Ativan	Ativan	IN	B-PP	O
0.5	0.5	CD	B-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	FW	I-NP	O
daily	daily	JJ	I-NP	O
p.r.n.	p.r.n.	NN	I-NP	O
anxiety	anxiety	NN	I-NP	O
.	.	.	O	O

8	8	CD	B-NP	O
.	.	.	O	O

Meclizine	Meclizine	NN	B-NP	O
12.5	12.5	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	FW	B-NP	O
t.i.d.	t.i.d.	FW	I-NP	O
p.r.n.	p.r.n.	FW	I-NP	O
dizziness	dizziness	NN	I-NP	O
.	.	.	O	O

9	9	CD	B-NP	O
.	.	.	O	O

Nitroglycerin	Nitroglycerin	NN	B-NP	O
1/150	1/150	CD	I-NP	O
one	one	CD	I-NP	O
tablet	tablet	NN	I-NP	O
sublingual	sublingual	JJ	B-NP	O
every	every	DT	I-NP	O
five	five	CD	I-NP	O
minutes	minute	NNS	I-NP	O
x3	x3	CD	I-NP	O
doses	dose	NNS	I-NP	O
p.r.n.	p.r.n.	VBP	B-VP	O
chest	chest	NN	B-NP	O
pain	pain	NN	I-NP	O
.	.	.	O	O

10	10	CD	B-NP	O
.	.	.	O	O

Compazine	Compazine	NN	B-NP	O
10mg	10mg	CD	I-NP	O
p.o.	p.o.	FW	I-NP	O
q.	q.	FW	I-NP	O
6h	6h	NN	I-NP	O
.	.	.	O	O

p.r.n.	p.r.n.	LS	B-NP	O
nausea	nausea	NN	I-NP	O
.	.	.	O	O

11	11	CD	B-NP	O
.	.	.	O	O

Imdur	Imdur	IN	B-PP	O
120	120	CD	B-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	RB	B-ADVP	O
daily	daily	RB	I-ADVP	O
.	.	.	O	O

12	12	CD	B-NP	O
.	.	.	O	O

Avapro	Avapro	RB	B-NP	O
25	25	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	RB	B-ADVP	O
daily	daily	RB	I-ADVP	O
.	.	.	O	O

13	13	CD	B-NP	O
.	.	.	O	O

Celexa	Celexa	NN	B-NP	O
10	10	CD	I-NP	O
mg	mg	NN	I-NP	O
daily	daily	RB	B-ADVP	O
.	.	.	O	O

14	14	CD	B-NP	O
.	.	.	O	O

Nexium	Nexium	NN	B-NP	O
20	20	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	RB	B-ADVP	O
daily	daily	RB	I-ADVP	O
.	.	.	O	O

15	15	CD	B-NP	O
.	.	.	O	O

Lipitor	Lipitor	NN	B-NP	O
20	20	CD	I-NP	O
mg	mg	NN	I-NP	O
daily	daily	RB	B-ADVP	O
.	.	.	O	O

eScription	eScription	NN	B-NP	O
document	document	NN	I-NP	O
:	:	:	O	O
9-6618364	9-6618364	CD	B-NP	O
EMSSten	EMSSten	NNP	I-NP	O
Tel	Tel	NNP	I-NP	O
Dictated	Dictated	NNP	I-NP	O
By	By	NNP	I-NP	O
:	:	:	O	O
FILMER	FILMER	NNP	B-NP	O
,	,	,	O	O
JAE	JAE	NNP	B-NP	O
Attending	Attending	NNP	I-NP	O
:	:	:	O	O
BURBA	BURBA	NNP	B-NP	O
,	,	,	O	O
ANTHONY	ANTHONY	NNP	B-NP	O
Dictation	Dictation	NNP	I-NP	O
ID	ID	NNP	I-NP	O
8475295	8475295	CD	I-NP	O
D	D	NNP	I-NP	O
:	:	:	O	O
6/17/05	6/17/05	CD	B-NP	O
T	T	NN	I-NP	O
:	:	:	O	O
6/17/05	6/17/05	CD	B-NP	O

